Can Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Can Fite Biopharma
CANF Stock  USD 1.65  0.02  1.23%   
Can Fite financial statements provide useful quarterly and yearly information to potential Can Fite Biopharma investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Can Fite financial statements helps investors assess Can Fite's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Can Fite's valuation are summarized below:
Gross Profit
667 K
Market Capitalization
9.9 M
Enterprise Value Revenue
7.2122
Revenue
667 K
Earnings Share
(2.60)
There are over one hundred nineteen available fundamental signals for Can Fite Biopharma, which can be analyzed over time and compared to other ratios. Active traders should verify all of Can Fite Biopharma prevailing fundamental drivers against the trend between 2010 and 2025 to make sure the company can sustain itself down the road. The current Market Cap is estimated to decrease to about 10.4 M. Enterprise Value is estimated to decrease to about 5.7 M

Can Fite Total Revenue

1.12 Million

Check Can Fite financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Can Fite's main balance sheet or income statement drivers, such as Depreciation And Amortization of 21.5 K, Interest Expense of 15.3 K or Total Revenue of 1.1 M, as well as many indicators such as Price To Sales Ratio of 13.96, Dividend Yield of 0.0 or PTB Ratio of 1.3. Can financial statements analysis is a perfect complement when working with Can Fite Valuation or Volatility modules.
  
Check out the analysis of Can Fite Correlation against competitors.

Can Fite Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding4.7 M4.9 M119 M
Slightly volatile
Total Assets10.5 M11.5 M9.4 M
Slightly volatile
Other Current Liabilities891.4 K1.1 M790.7 K
Pretty Stable
Total Current Liabilities2.4 M2.3 M2.1 M
Slightly volatile
Other Liabilities2 M2.6 M1.8 M
Slightly volatile
Property Plant And Equipment Net87.2 K93.2 K80.2 K
Slightly volatile
Accounts Payable365.1 K384.3 K968.6 K
Slightly volatile
Cash4.6 M3.9 M5.5 M
Pretty Stable
Non Current Assets Total88.5 K93.2 K197 K
Pretty Stable
Cash And Short Term Investments8.4 M10.3 M7.6 M
Slightly volatile
Net Receivables66.7 K70.2 K731.5 K
Pretty Stable
Common Stock Total Equity39.9 M38 M14.5 M
Slightly volatile
Liabilities And Stockholders Equity10.5 M11.5 M9.4 M
Slightly volatile
Non Current Liabilities Total2.4 M2 M2 M
Slightly volatile
Other Stockholder Equity106.5 M188.1 M100.8 M
Slightly volatile
Total Liabilities4.8 M4.3 M4.2 M
Slightly volatile
Property Plant And Equipment Gross415.4 K395.6 K136.2 K
Slightly volatile
Total Current Assets10.3 M11.4 M9.2 M
Slightly volatile
Accumulated Other Comprehensive Income963.6 K1 M3.2 M
Slightly volatile
Common Stock73.2 M69.8 M23.7 M
Slightly volatile
Property Plant Equipment84.8 K144.9 K84.6 K
Slightly volatile
Net Tangible Assets7.2 M4 M9.1 M
Slightly volatile
Current Deferred Revenue594.8 K715.3 K454.7 K
Slightly volatile
Capital Surpluse72 M86.1 M91.8 M
Slightly volatile
Deferred Long Term Liabilities1.1 M1.1 M982 K
Slightly volatile
Non Current Liabilities Other1.9 M1.8 M2.3 M
Slightly volatile
Net Invested Capital6 M7.2 M4.5 M
Slightly volatile
Net Working Capital8.4 M9.1 M6.7 M
Slightly volatile
Short Term Investments4.5 M5.3 M2.3 M
Slightly volatile
Short and Long Term Debt Total58.9 K36 K71.1 K
Slightly volatile
Long Term Debt Total31.2 K35.1 K38.3 K
Slightly volatile
Capital Lease Obligations58.9 K36 K71.1 K
Slightly volatile

Can Fite Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization21.5 K13.5 K25.7 K
Slightly volatile
Other Operating Expenses10 M10.3 M9.2 M
Slightly volatile
Research Development6.8 M6.9 M6.2 M
Slightly volatile
Total Operating Expenses10 M10.3 M9.2 M
Slightly volatile
Selling General Administrative3.4 M3.4 M3.1 M
Slightly volatile
Selling And Marketing Expenses23.7 K13.5 K25.7 K
Slightly volatile
Interest Income287.6 K455.4 K922.2 K
Slightly volatile
Reconciled Depreciation15 K13.5 K18.6 K
Slightly volatile

Can Fite Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation350.5 K300.1 K319.4 K
Very volatile
Begin Period Cash Flow4.6 M2.7 M5.5 M
Pretty Stable
Depreciation18.6 K13.5 K22.3 K
Slightly volatile
Capital Expenditures1.7 K1.8 K14.2 K
Slightly volatile
End Period Cash Flow4.6 M3.9 M5.5 M
Pretty Stable
Sale Purchase Of Stock16.1 M9.2 M21.5 M
Slightly volatile
Issuance Of Capital Stock12.5 M10.5 M7.9 M
Slightly volatile
Dividends Paid1.8 M3 M1.2 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio13.9614.781.4472
Slightly volatile
Days Sales Outstanding23.1424.3653.1464
Slightly volatile
Average Payables919.2 K963.6 K900.9 K
Slightly volatile
Stock Based Compensation To Revenue0.520.40.5034
Pretty Stable
Capex To Depreciation0.110.120.793
Very volatile
EV To Sales7.738.1448.9562
Slightly volatile
Sales General And Administrative To Revenue6.644.579.2176
Slightly volatile
Research And Ddevelopement To Revenue12.849.2613.795
Pretty Stable
Capex To Revenue0.00290.00310.0833
Slightly volatile
Cash Per Share0.00760.0080.2036
Slightly volatile
Income Quality0.81.00.9867
Very volatile
Net Debt To EBITDA0.780.60.6987
Pretty Stable
Current Ratio3.694.414.4753
Pretty Stable
Receivables Turnover12.4215.5111.2802
Slightly volatile
Debt To Equity0.0070.00740.0226
Slightly volatile
Capex Per Share0.00.07.0E-4
Slightly volatile
Average Receivables11.9 K12.6 K18.2 K
Slightly volatile
Revenue Per Share6.0E-47.0E-40.0203
Slightly volatile
Interest Debt Per Share0.00.00.0113
Slightly volatile
Debt To Assets0.00730.00460.008
Slightly volatile
Operating Cycle23.1424.3653.1464
Slightly volatile
Ebt Per Ebit1.091.070.9996
Very volatile
Total Debt To Capitalization0.0070.00730.022
Slightly volatile
Debt Equity Ratio0.0070.00740.0226
Slightly volatile
Quick Ratio3.944.414.7458
Pretty Stable
Net Income Per E B T0.790.930.9733
Very volatile
Cash Ratio3.422.443.0741
Pretty Stable
Cash Conversion Cycle23.1424.3653.1464
Slightly volatile
Days Of Sales Outstanding23.1424.3653.1464
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.11.151.0181
Slightly volatile
Fixed Asset Turnover17.1210.5512.3658
Pretty Stable
Debt Ratio0.00730.00460.008
Slightly volatile
Price Sales Ratio13.9614.781.4472
Slightly volatile
Asset Turnover0.0960.06690.0956
Pretty Stable

Can Fite Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap10.4 M10.9 M24.2 M
Slightly volatile
Enterprise Value5.7 M6 M17.7 M
Slightly volatile

Can Fundamental Market Drivers

Forward Price Earnings2.9665
Cash And Short Term Investments8.9 M

Can Upcoming Events

4th of April 2024
Upcoming Quarterly Report
View
6th of June 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Can Fite Financial Statements

Can Fite stakeholders use historical fundamental indicators, such as Can Fite's revenue or net income, to determine how well the company is positioned to perform in the future. Although Can Fite investors may analyze each financial statement separately, they are all interrelated. For example, changes in Can Fite's assets and liabilities are reflected in the revenues and expenses on Can Fite's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Can Fite Biopharma. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue715.3 K594.8 K
Total Revenue854.5 K1.1 M
Cost Of Revenue13.5 K12.8 K
Stock Based Compensation To Revenue 0.40  0.52 
Sales General And Administrative To Revenue 4.57  6.64 
Research And Ddevelopement To Revenue 9.26  12.84 
Ebit Per Revenue(9.93)(10.42)

Currently Active Assets on Macroaxis

VVisa Class A
CRMSalesforce
CRMSalesforce
MSFTMicrosoft
VVisa Class A
When determining whether Can Fite Biopharma is a strong investment it is important to analyze Can Fite's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Can Fite's future performance. For an informed investment choice regarding Can Stock, refer to the following important reports:
How To Invest In Can
Details
Is Can Stock a good investment?
Details
What is Can Fite's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Can Fite Correlation against competitors.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Can Fite. If investors know Can will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Can Fite listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.60)
Quarterly Revenue Growth
(0.19)
Return On Assets
(0.57)
Return On Equity
(1.58)
The market value of Can Fite Biopharma is measured differently than its book value, which is the value of Can that is recorded on the company's balance sheet. Investors also form their own opinion of Can Fite's value that differs from its market value or its book value, called intrinsic value, which is Can Fite's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Can Fite's market value can be influenced by many factors that don't directly affect Can Fite's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Can Fite's value and its price as these two are different measures arrived at by different means. Investors typically determine if Can Fite is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Can Fite's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY